Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies

Background: New technologies constitute an important cost-driver in healthcare, but the dynamics that lead to their emergence remains poorly understood from a health policy standpoint. The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehoux, Pascale, Miller, Fiona A., Daudelin, Geneviève, Denis, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582437/
https://www.ncbi.nlm.nih.gov/pubmed/28949463
http://dx.doi.org/10.15171/ijhpm.2017.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582437/
https://www.ncbi.nlm.nih.gov/pubmed/28949463
http://dx.doi.org/10.15171/ijhpm.2017.11

Ejemplares similares